METASTATIC MALIGNANT NEOPLASM
Clinical trials for METASTATIC MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Freezing cancer cells: new combo therapy shows promise in metastatic disease
Disease control OngoingThis study looks at whether freezing cancerous tumors (cryoablation) can boost the effects of standard immunotherapy in people with metastatic cancer. About 15 participants will receive cryoablation on top of their usual treatment. The goal is to see if this combination leads to …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:37 UTC
-
New drug cocktail trial aims to tame tough tumors
Disease control OngoingThis early-phase trial tests the safety and best doses of two drugs (bevacizumab and temsirolimus) given alone or with other medicines (valproic acid or cetuximab) in people with advanced cancer or certain non-cancerous diseases that are hard to treat. The goal is to find the hig…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New study aims to find better radiation option for brain metastases
Disease control OngoingThis study compares two radiation treatments for people whose cancer has spread to the brain (but not from melanoma). One is stereotactic radiosurgery, which targets tumors precisely with a high dose. The other is whole brain radiation, which treats the entire brain with lower do…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for tough cancers: drug targets BRCA mutations
Disease control OngoingThis study tests a drug called talazoparib in people with advanced cancers that have not responded to standard treatments. The drug works by blocking an enzyme that helps cancer cells survive, especially in tumors with changes in the BRCA genes or related DNA repair genes. The go…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Fatigue-Busting combo for cancer patients shows promise in new study
Symptom relief OngoingThis study looks at whether a medication called methylphenidate (often used for ADHD) combined with physical activity can reduce severe tiredness in people with advanced cancer who are on immunotherapy. About 212 participants will be randomly assigned to receive either the drug o…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 11:37 UTC
-
Can a common antipsychotic ease delirium in dying cancer patients?
Symptom relief OngoingThis study looks at whether haloperidol, given alone or with chlorpromazine, can safely reduce severe agitation and confusion (delirium) in people with advanced cancer who are in a palliative care unit. About 70 participants will receive the drugs and be monitored for 24 hours. T…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 11:36 UTC
-
Exercise plus steroid shows promise for cancer fatigue
Symptom relief OngoingThis study tests whether adding a short course of the steroid dexamethasone to a physical activity program can reduce severe fatigue in people with advanced cancer. About 90 participants will be randomly assigned to receive either a high or low dose of dexamethasone along with ex…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 11:35 UTC
-
New hope for calming agitated delirium in dying cancer patients
Symptom relief OngoingThis study looks at how well two drugs, haloperidol and lorazepam, can control severe agitation and confusion (delirium) in advanced cancer patients receiving palliative care. About 110 patients whose delirium did not improve with low-dose haloperidol will be given different drug…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 12:03 UTC
-
Do cancer patients prefer the exam room over the waiting room?
Knowledge-focused OngoingThis study looks at whether cancer patients and their caregivers prefer to wait in an exam room instead of a waiting room when visiting a supportive care clinic. About 406 participants will share their opinions through a questionnaire. The goal is to understand what makes the cli…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 11:34 UTC
-
Gene test vs. standard care: which works better for advanced cancer?
Knowledge-focused OngoingThis study looks at whether analyzing the genetic changes in a patient's tumor can help doctors pick a more effective targeted therapy for metastatic cancer. Over 1,300 patients with cancer that has spread are randomly assigned to receive either a treatment chosen based on their …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 11:34 UTC
-
Cancer's hidden cost: study reveals financial burden on patients
Knowledge-focused OngoingThis study looks at how serious money problems are for people with advanced cancer. Cancer care can be very expensive, and the stress from debt and high costs may make physical symptoms and quality of life worse. About 141 patients will fill out a short survey to measure their fi…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC